Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1243

2.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
3.

Cardiovascular disease and diabetes in people with severe mental illness.

Hert MD, Dekker JM, Wood D, Kahl KG, Möller HJ.

Rev Psiquiatr Salud Ment. 2009 Mar;2(1):49-59. doi: 10.1016/S1888-9891(09)70714-1. Epub 2009 May 6. English, Spanish.

4.

Development of a health screening clinic.

Millar HL.

Eur Psychiatry. 2010 Jun;25 Suppl 2:S29-33. doi: 10.1016/S0924-9338(10)71703-X.

PMID:
20620883
5.

Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.

Newcomer JW.

J Clin Psychiatry. 2009;70 Suppl 3:30-6. doi: 10.4088/JCP.7075su1c.05. Review.

6.

Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder.

Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB.

Arch Gen Psychiatry. 2009 Jul;66(7):713-20. doi: 10.1001/archgenpsychiatry.2009.61.

PMID:
19581562
7.
8.

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].

Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.

Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. Review. French.

PMID:
16389718
9.

Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.

Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks FM.

J Clin Psychiatry. 2005 Feb;66(2):183-94; quiz 147, 273-4. Review.

PMID:
15705003
10.

Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1116-21.

PMID:
16187768
11.

Medical risk in patients with bipolar disorder and schizophrenia.

Newcomer JW.

J Clin Psychiatry. 2006 Nov;67(11):e16.

12.

Metabolic syndrome and mental illness.

Newcomer JW.

Am J Manag Care. 2007 Nov;13(7 Suppl):S170-7. Review. Erratum in: Am J Manag Care. 2008 Feb;14(2):76.

13.

Risk of cardiovascular disease and sudden death in schizophrenia.

Davidson M.

J Clin Psychiatry. 2002;63 Suppl 9:5-11. Review. Erratum in: J Clin Psychiatry 2002 Aug;63(8):744.

14.

Metabolism, lifestyle and bipolar affective disorder.

Morriss R, Mohammed FA.

J Psychopharmacol. 2005 Nov;19(6 Suppl):94-101. Review.

PMID:
16280342
15.
16.

The comorbidity of diabetes mellitus and psychiatric disorders.

Medved V, Jovanović N, Knapić VP.

Psychiatr Danub. 2009 Dec;21(4):585-8. Review.

17.

Medical risk in patients with bipolar disorder and schizophrenia.

Newcomer JW.

J Clin Psychiatry. 2006;67 Suppl 9:25-30; discussion 36-42. Review.

18.

The comorbidity of bipolar disorder and cardiovascular diseases from pharmacotherapy perspective.

Vuksan-Cusa B, Marcinko D, Sagud M, Jakovljević M.

Psychiatr Danub. 2009 Sep;21(3):382-5.

19.

The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada.

Callaghan RC, Khizar A.

J Affect Disord. 2010 Apr;122(1-2):118-23. doi: 10.1016/j.jad.2009.06.029. Epub 2009 Aug 3.

PMID:
19647877
20.

Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV.

J Affect Disord. 2002 Jun;70(1):19-26. Erratum in: J Affect Disord. 2003 Feb;73(3):301-2..

PMID:
12113916
Items per page

Supplemental Content

Write to the Help Desk